S. Boellner

发表

Pharmacokinetics of a Guanfacine Extended‐Release Formulation in Children and Adolescents with Attention‐Deficit–Hyperactivity Disorder

A. Lyne, K. Fiske, S. Boellner, 2007, Pharmacotherapy.

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

R. Findling, H. Abikoff, O. Bukstein, 2009, Clinical therapeutics.

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group,

J. Biederman, T. Spencer, H. Abikoff, 2006, Clinical therapeutics.

Primary acquired lactase deficiency with acquired hypogammaglobulinemia. Report of a case and review of the literature.

S. Boellner, K. Caplinger, 1968, American journal of diseases of children.

Improvements in Symptoms of Attention-Deficit/Hyperactivity Disorder in School-Aged Children with Lisdexamfetamine Dimesylate [LDX; NRP104] and Mixed Amphetamine Salts Extended-Release vs. Placebo

J. Biederman, F. López, A. Childress, 2006 .

Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years

P. Ward, Baolian Liu, C. Oo, 2003, European Journal of Clinical Pharmacology.

A single‐dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures

G. Granneman, K. Sommerville, L. Gustavson, 1997, Neurology.

PLASMA AND ERYTHROCYTE MAGNESIUM IN MUSCULAR DYSTROPHY.

E. R. Hughes, S. Boellner, D. Fredrickson, 1965, American journal of diseases of children.

Disaccharide intolerance.

S. Boellner, 1966, The Journal of the Arkansas Medical Society.

Single‐Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children

D. Ouellet, E. Posvar, E. Randinitis, 2001, Journal of clinical pharmacology.

Congenital arteriovenous fistula of the vertebral artery and internal jugular vein.

J. Suen, S. Boellner, W. Boop, 1972, The Journal of pediatrics.

Lack of Pharmacokinetic Drug Interactions Between Tiagabine and Carbamazepine or Phenytoin

G. Cao, K. Sommerville, L. Gustavson, 1998, American journal of therapeutics.

Lack of a Clinically Significant Pharmacokinetic Drug Interaction Between Tiagabine and Valproate

G. Granneman, K. Sommerville, L. Gustavson, 1998, American journal of therapeutics.

Impairment of intestinal hydrolysis of lactose in newborn infants.

S. Boellner, A. Beard, T. Panos, 1965, Pediatrics.

A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder.

J. Swanson, J. Biederman, L. Greenhill, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study

J. Swanson, J. Biederman, L. Greenhill, 2005, Pediatrics.

Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder.

T. Wilens, H. Abikoff, M. Manos, 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study.

J. Stark, S. Krishnan, Yuxin Zhang, 2010, Clinical therapeutics.

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder.

J. Biederman, S. Boellner, F. López, 2002, Pediatrics.

Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study

J. Biederman, A. Childress, S. Krishnan, 2007, Biological Psychiatry.

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

J. Swanson, J. Biederman, S. Wigal, 2006, The Journal of clinical psychiatry.

Modafinil in children and adolescents with attention-deficit/hyperactivity disorder:a preliminary 8-week, open-label study*

S. Arora, S. Boellner, C. Earl, 2006, Current medical research and opinion.